Reducing diabetics' hypoglycaemic events

November 25, 2013 by Sophie Hepburn
Reducing diabetics’ hypoglycaemic events
No seizure or coma episodes occurred in the group using sensor-augmented pumps despite these continuing at the same rate in the standard insulin therapy group. Credit: Alden Chadwick

Insulin pumps that can respond to blood glucose concentration can reduce the rate of severe hypoglycaemia (low blood glucose) in type 1 diabetics, according to the results of a recent trial.

The clinical trial was recently published in The Journal of the American Medical Association and showed that the average duration of was also significantly lower in individuals using sensor-augmented compared to those using standard insulin pump therapy.

The sensor-augmented pump, released in 2009, automatically suspends insulin delivery for up to two hours when glucose levels fall below a threshold concentration.

In this study, sensor-augmented pumps were compared to standard insulin pumps for a period of six months in 95 individuals with type 1 diabetes and impaired hypoglycaemia awareness.

Impaired awareness of hypoglycaemia occurs in about 30 per cent of type 1 diabetics whose risk of severe hypoglycaemic events is 3-6 times greater than those without reduced awareness.

Princess Margaret Hospital Department of Endocrinology and Diabetes Professor Timothy W Jones says that "the major known factor leading to impaired awareness is hypoglycaemia itself, which reduces symptom responsiveness in individuals".

Study participants were recruited from hospitals in WA between December 2009 and January 2012, and had previously been treated with standard insulin pump therapy for at least six months.

The researchers monitored the incidence of severe (seizures or coma) and moderate (requiring treatment/intervention) hypoglycaemia.

"Severe hypoglycaemia results in confusion and drowsiness, and if more severe unconsciousness and seizures," Prof Jones says.

A majority of severe hypoglycaemia episodes occur during the night, but alarm systems are only partially effective as patients may not wake up to the sound of an alarm.

At the end of the six month trial period, low glucose levels during the overnight period were lower in patients using the sensor-augmented pump.

In addition, no seizure or coma episodes occurred in the group using sensor-augmented pumps despite these continuing at the same rate in the standard insulin therapy group.

The sensor-augmented pumps reduced the duration and magnitude of hypoglycaemia but did not eliminate it altogether.

"As the systems develop further and become easier to use, they are likely to become standard therapy," Prof Jones says.

He says that the next step will be to predict a hypoglycaemic episode before it occurs.

"We are about to start a trial of a system that has an algorithm embedded that predicts hypoglycaemia and switches off insulin prior to hypoglycaemia developing," he says.

Explore further: Sensor-augmented insulin pump therapy reduces rate of severe hypoglycemic events

Related Stories

Sensor-augmented insulin pump therapy reduces rate of severe hypoglycemic events

September 24, 2013
Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes and impaired awareness ...

Cardiovascular risk in type 2 diabetics with dangerously low blood sugar levels

July 30, 2013
Type 2 diabetics who have severe hypoglycaemia are at higher risk of cardiovascular disease, a paper published today in BMJ suggests.

Insulin pumps to treat type 1 diabetes in children control blood sugar more effectively than injections

August 18, 2013
The longest and largest study of the effectiveness of insulin pumps to treat type 1 diabetes in children has shown that the pumps are more effective at controlling blood sugar than insulin injections and cause fewer complications. ...

ADA: insulin-pump tx with threshold-suspend beneficial

June 24, 2013
(HealthDay)—For patients with type 1 diabetes and documented nocturnal hypoglycemia, insulin-pump therapy with a threshold-suspend feature reduces nocturnal hypoglycemia over a three-month period, according to a study published ...

Artificial pancreas may improve overnight control of diabetes in adults

April 15, 2011
Two small randomised trials published in the British Medical Journal today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.